This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.


Bernard Coulie
President and CEO at Pliant Therapeutics


Bernard Coulie, M.D., Ph.D., is serving as President and Chief Executive Officer of Pliant Therapeutics, a biopharma company focused on delivering novel treatments for patients with fibrotic diseases. Under his leadership, Pliant raised over $200 Million in capital, including a partnership agreement with Novartis covering Pliant’s program in NASH-liver fibrosis. He joined Pliant in 2016 from ActoGeniX, where he was CEO, Chief Medical Officer and Co-Founder. Prior to ActoGeniX, he held various positions in drug discovery and clinical development at Johnson & Johnson Pharmaceutical Research and Development Europe. At Johnson & Johnson, he served as Therapeutic Area Leader Internal Medicine, managing a portfolio of preclinical and clinical products in GI, metabolic diseases and inflammation/immunology. Earlier in his career, Dr. Coulie was a Staff Physician in the Department of Gastroenterology and Hepatology at Mayo Clinic (Rochester, MN), Assistant Professor in Medicine at Mayo Medical School and a Mayo Foundation scholar.

Bernard Coulie's Network

Agenda Sessions

  • Metabolic disease, fibrosis and NASH - Hilton Union Square


Speakers at this event